In patients with chronic hepatitis C, the therapeutic effect of interf
eron (IFN) is influenced by the progression of liver disease. In a pre
vious study, we showed that 2',5'-oligoadenylate synthetase activity i
n the liner homogenate was significantly lower in cirrhotic rats than
in controls after injection of murine IFN. To determine the reason for
this decrease, we injected IFN into rats with thioacetamide-induced c
irrhosis and used microautoradiography with human lymphoblastoid inter
feron ([I-125]LyIFN). Accumulation of [I-125]LyIFN in cirrhotic rat li
vers was approximately half of that in control rats (2880 +/- 900 vs 5
770 +/- 600 mm(2), P < 0.01). In the cirrhotic rat livers there were f
ew grains on the hepatocytes, but many on collagen fibres. These resul
ts suggest that binding of IFN to its hepatocyte receptors is hindered
in the presence of cirrhosis, The decreased amount of IFN reaching he
patocytes may contribute to the poor responses to IFN seen in patients
with cirrhosis.